Federico Oppenheimer

The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy (2009)

Ekberg, Henrik, Mamelok, Richard D, Oppenheimer, Federico, Sánchez-Plumed, Jaime, Gentil, Miguel Angel, ...

BACKGROUND: Exposure to mycophenolic acid (MPA), the primary active metabolite of mycophenolate mofetil (MMF), is correlated with therapeutic efficacy of MMF but varies depending on the concomitantly...

The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy (2009)

Grinyó, Josep M., Ekberg, Henrik, Mamelok, Richard D., Oppenheimer, Federico, Sánchez-Plumed, Jaime, Gentil, Miguel Angel, ...

Background. Exposure to mycophenolic acid (MPA), the primary active metabolite of mycophenolate mofetil (MMF), is correlated with therapeutic efficacy of MMF but varies depending on the concomitantly...

Influence of sirolimus on proteinuria in de novo kidney transplantation with expanded criteria donors: comparison of two CNI-free protocols (2007)

Diekmann, Fritz, Gutiérrez-Dalmau, Alex, López, Sonia, Cofán, Federico, Esforzado, Núria, Ricart, María José, ...

Background. The contribution of mammalian target of rapamycin (mTOR) inhibitors to proteinuria is controversial. The aim was to analyse proteinuria in suboptimal kidney calcineurin inhibitor-(CNI)...

Conversion from calcineurin inhibitors to sirolimus in chronic allograft dysfunction: changes in glomerular haemodynamics and proteinuria (2006)

Saurina, Anna, Campistol, Josep M., Piera, Carlos, Diekmann, Fritz, Campos, Begoña, Campos, Nieves, ...

Background. The study was conducted in order to describe possible intraglomerular haemodynamic changes inducing proteinuria after 14 patients with chronic allograft dysfunction were converted from...

Conversion from calcineurin inhibitors to sirolimus in chronic allograft dysfunction: changes in glomerular haemodynamics and proteinuria (2005)

Saurina, Anna, Campistol, Josep M., Piera, Carlos, Diekmann, Fritz, Campos, Begoña, Campos, Nieves, ...

Background. The study was conducted in order to describe possible intraglomerular haemodynamic changes inducing proteinuria after 14 patients with chronic allograft dysfunction were converted from...

Conversion from calcineurin inhibitors to sirolimus in chronic allograft dysfunction: changes in glomerular haemodynamics and proteinuria (2005)

Saurina, Anna, Campistol, Josep M., Piera, Carlos, Diekmann, Fritz, Campos, Begoña, Campos, Nieves, ...

Background. The study was conducted in order to describe possible intraglomerular haemodynamic changes inducing proteinuria after 14 patients with chronic allograft dysfunction were converted from...

The impact of donor age on the results of renal transplantation (2004)

Oppenheimer, Federico, Aljama, Pedro, Asensio Peinado, Concepción, Bustamante Bustamante, Jesús, Crespo Albiach, Jose Francisco, Guirado Perich, Luis

Background. The use of elderly donors is becoming more frequent. An increase in the donor's age is associated with a greater incidence of delayed graft function (DGF), chronic allograft nephropathy...

Role of transforming growth factor-{beta}1 in the progression of chronic allograft nephropathy (2001)

Campistol, Josep M., Iñigo, Pablo, Larios, Sergio, Bescos, Mónica, Oppenheimer, Federico

Chronic allograft nephropathy is the principal cause of late graft loss after the first year of renal transplantation. Transforming growth factor‐β1 (TGF‐β1) is a key...